Hiroshi Hikida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hiroshi Hikida has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Atulya Aman Khosla
Department of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA
1 shared publication - Fadi Salem
Mayo Clinic, Jacksonville, Florida
1 shared publication - Hassan Baig
Division of Pulmonary, Allergy, Sleep and Respiratory Medicine, Mayo Clinic
1 shared publication - Hollie Saunders
Mayo Clinic, Jacksonville, FL, United States
1 shared publication Nabeel Aslam
Mayo Clinic Florida, Jacksonville, FL 32224, USA
1 shared publicationSam Albadri
Mayo Clinic Florida, Jacksonville, FL 32224, USA
1 shared publication
Latest Publications
- Open Access
- 15 April 2023
- Published by Hindawi Limited in Case Reports in Pulmonology
- Vol. 2023, 1-4
The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
Hydralazine is a vasodilator used for the management of hypertension, heart failure, and hypertensive emergencies in pregnancy. It has been implicated in the causation of drug-induced lupus erythematosus (DLE) and rarely with ANCA-associated vasculitis (AAV), which may present as a pulmonary-renal syndrome and be rapidly fatal. Herein, we describe a case of hydralazine-associated AAV presenting as acute kidney injury with the use of early bronchoalveolar lavage (BAL) with serial aliquots to aid with diagnosis. Our case highlights how, in the correct clinical setting, BAL can act as a rapid diagnostic test to help guide quicker treatment to allow for better patient outcomes.
- 15 April 2023
- Published by Hindawi Limited in Case Reports in Pulmonology
- Vol. 2023, 1-4
Open AccessThe Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
Hydralazine is a vasodilator used for the management of hypertension, heart failure, and hypertensive emergencies in pregnancy. It has been implicated in the causation of drug-induced lupus erythematosus (DLE) and rarely with ANCA-associated vasculitis (AAV), which may present as a pulmonary-renal syndrome and be rapidly fatal. Herein, we describe a case of hydralazine-associated AAV presenting as acute kidney injury with the use of early bronchoalveolar lavage (BAL) with serial aliquots to aid with diagnosis. Our case highlights how, in the correct clinical setting, BAL can act as a rapid diagnostic test to help guide quicker treatment to allow for better patient outcomes.